The ethics of prescribing low- to no-efficacy stimulants

Christopher Langston

doi:10.1016/j.msard.2021.103386

The ethics of prescribing low- to no-efficacy stimulants

Neurology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	103386
Journal	Multiple Sclerosis and Related Disorders
Volume	57
DOIs	https://doi.org/10.1016/j.msard.2021.103386
State	Published - Jan 2022

Keywords

Addiction
Ethics
Placebo effect
Stimulant

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1016/j.msard.2021.103386

Cite this

@article{4783ba0e8c1440278c572327c217d5d3,

title = "The ethics of prescribing low- to no-efficacy stimulants",

keywords = "Addiction, Ethics, Placebo effect, Stimulant",

author = "Christopher Langston",

year = "2022",

month = jan,

doi = "10.1016/j.msard.2021.103386",

language = "English (US)",

volume = "57",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - The ethics of prescribing low- to no-efficacy stimulants

AU - Langston, Christopher

PY - 2022/1

Y1 - 2022/1

KW - Addiction

KW - Ethics

KW - Placebo effect

KW - Stimulant

UR - http://www.scopus.com/inward/record.url?scp=85124292458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124292458&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2021.103386

DO - 10.1016/j.msard.2021.103386

M3 - Letter

C2 - 35158436

AN - SCOPUS:85124292458

SN - 2211-0348

VL - 57

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

M1 - 103386

ER -

The ethics of prescribing low- to no-efficacy stimulants

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this